JDRF Western Wisconsin » aaron kowalski

Live Webcast with Dr. Aaron Kowalski! Tune in March 8

Western Wisconsin — Thu, 03 Mar 2011 19:09:44 +0000

Join Our Live Webcast on March 8 at 1pm EST with JDRF’s Aaron Kowalski
As many of you can attest, type 1 diabetes is a difficult disease to live with. Despite progress made in diabetes management, people still need better tools and technology to help them live better with the disease.

Steps toward a fully-automated system continue to advance, adding to the prospect that artificial pancreas devices could eventually become available for people with type 1 diabetes. Mounting evidence of research funded by JDRF and others suggests an artificial pancreas, which would automatically control high and low blood sugar around the clock, has the potential to transform the care of people with type 1 diabetes, enabling them to live longer and healthier lives.

Artificial pancreas technologies have shown success in improving glucose control when tested in controlled in-patient or hospital settings. Now they have to be put to the test in real-life situations. In fact, the U.S. Food and Drug Administration (FDA) convened a workshop in November to discuss next steps in the testing of these devices. There was general consensus among researchers, clinicians, and patients at the workshop that it is time to start testing these systems outside of the hospital.

But the FDA needs to provide clear and reasonable guidance when reviewing and approving artificial pancreas trials before they can proceed. Having guidance from FDA will accelerate the ability of researchers and companies to develop this much-needed technology for patients with type 1 diabetes. However, without clear and reasonable guidance to allow outpatient studies on the device from the FDA, the development of this transformative technology could be delayed.

Come join JDRF’s Aaron Kowalski for the latest developments on the artificial pancreas and next steps on how we can move testing safely and effectively into outpatient settings. Find out what JDRF is doing, and what you can do to help.

So, please tune-in to www.jdrf.org/livewebcasts on March 8 at 1pm EST to join our discussion. If you are unable to watch live, the webcast will be recorded and archived in the same location on our site.

In the meantime, if you have any questions, please let us know. You can find us on Twitter, Facebook, or just email us at advocacy@jdrf.org.

Thanks!

Live Webcast with JDRF’s Aaron Kowalski

Western Wisconsin — Thu, 16 Dec 2010 18:27:21 +0000

Friday, December 17 at 11:00am CDT
As part of JDRF’s monthly webcast series, we will be holding a live Q&A session with JDRF’s Assistant Vice President of Treatment Therapies, Dr. Aaron Kowalski. There have been some promising developments in the field of diabetes research over the last month, and we imagine you might have some questions about what you’ve heard. We would like to share this progress with you, and also discuss any other type 1 diabetes-related topics you may have! Participation is easy; just visit www.jdrf.org/livewebcasts on Friday, December 17 at 11:00am CDT

Dr. Aaron Kowalski Webcast: today

Western Wisconsin — Wed, 27 Jan 2010 16:26:44 +0000

As a reminder, Dr. Aaron Kowalski, will lead a webcast today, Wednesday, January 27, at noon EST about JDRF’s exciting new partnerships with partnerships with J&J/Animas and Becton Dickinson.

Be sure to join JDRF for the live video event at noon EST. The program is scheduled to last 1 hour. The video will be streamed through our Promise Campaign blog. You can access it by clicking this link. Aaron will start by providing answers to as many of your questions as he can. We’ll be streaming our video with the help of Ustream. Ustream’s product allows participants to ask questions over the course of Aaron’s presentation. So, time permitting, Aaron will respond to those as well.